BCAL Diagnostics (ASX:BDX) Buyback Yield % : -8.67 (As of Jun. 07, 2024)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

BCAL Diagnostics's current buyback yield was -8.67%.

BCAL Diagnostics Buyback Yield % Historical Data

The historical data trend for BCAL Diagnostics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Buyback Yield % Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Buyback Yield %

-56.70

-0.34

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Buyback Yield %	Get a 7-Day Free Trial			-109.67	-0.36	-	-	-21.73

Competitive Comparison of BCAL Diagnostics's Buyback Yield %

For the Diagnostics & Research subindustry, BCAL Diagnostics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BCAL Diagnostics's Buyback Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's Buyback Yield % falls into.

BCAL Diagnostics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

BCAL Diagnostics's Buyback Yield for the fiscal year that ended in Jun. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0.05)	/	14.86205
	=	-0.34%

BCAL Diagnostics's annualized Buyback Yield for the quarter that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (-0.272	+	3.006)	*	2	/	25.1639
	=	-21.73%

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Dec. 2023) data.

BCAL Diagnostics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.